Lee HY - Search Results

1

Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.

Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY. Oh SH, et al. Among authors: lee hy. Clin Cancer Res. 2006 Jan 15;12(2):653-61. doi: 10.1158/1078-0432.CCR-05-1725. Clin Cancer Res. 2006. PMID: 16428512

2

Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.

Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Lee HY, et al. Cancer Res. 2002 Jun 15;62(12):3530-7. Cancer Res. 2002. PMID: 12068000

3

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.

Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY. Chang YS, et al. Among authors: lee hy. Clin Cancer Res. 2002 Dec;8(12):3669-75. Clin Cancer Res. 2002. PMID: 12473575

4

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.

Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY. Chang YS, et al. Among authors: lee hy. Clin Cancer Res. 2002 Dec;8(12):3796-802. Clin Cancer Res. 2002. PMID: 12473592

5

Implication of protein kinase B/Akt and Bcl-2/Bcl-XL suppression by the farnesyl transferase inhibitor SCH66336 in apoptosis induction in squamous carcinoma cells.

Chun KH, Lee HY, Hassan K, Khuri F, Hong WK, Lotan R. Chun KH, et al. Among authors: lee hy. Cancer Res. 2003 Aug 15;63(16):4796-800. Cancer Res. 2003. PMID: 12941797

6

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.

Chang YS, Wang L, Suh YA, Mao L, Karpen SJ, Khuri FR, Hong WK, Lee HY. Chang YS, et al. Among authors: lee hy. Oncogene. 2004 Aug 26;23(39):6569-80. doi: 10.1038/sj.onc.1207882. Oncogene. 2004. PMID: 15247904

7

Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.

Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK. Lee HY, et al. J Natl Cancer Inst. 2004 Oct 20;96(20):1536-48. doi: 10.1093/jnci/djh286. J Natl Cancer Inst. 2004. PMID: 15494604

8

Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.

Lee HY, Oh SH, Suh YA, Baek JH, Papadimitrakopoulou V, Huang S, Hong WK. Lee HY, et al. Clin Cancer Res. 2005 Aug 15;11(16):6065-74. doi: 10.1158/1078-0432.CCR-05-0009. Clin Cancer Res. 2005. PMID: 16115952

9

Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.

Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY. Han JY, et al. Among authors: lee hy. J Natl Cancer Inst. 2005 Sep 7;97(17):1272-86. doi: 10.1093/jnci/dji251. J Natl Cancer Inst. 2005. PMID: 16145048

10

The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.

Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK, Lee HY. Papadimitrakopoulou VA, et al. Among authors: lee hy. Cancer Lett. 2006 Jul 28;239(1):136-43. doi: 10.1016/j.canlet.2005.08.009. Epub 2005 Sep 21. Cancer Lett. 2006. PMID: 16181731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,419 results

Search Page

Filters